06.27.2013 1

Americans for Limited Government leads opposition to frivolous generic drug lawsuits

By ALG Staff

Americans for Limited Government has delivered a letter to House Speaker John Boehner signed by leaders of eight major organizations urging his “opposition to legislation that would drive up healthcare costs and line the pockets of trial lawyer by opening generic drug manufacturers to frivolous lawsuits.”

The letter signed by leaders of Americans for Limited Government, the Competitive Enterprise Institute, the Hispanic Leadership Fund, American Commitment, King Street Patriots, LessGovernment.org, Independent Women’s Forum and Congress On Racial Equality is particularly relevant given today’s Supreme Court decision in Mutual Pharmaceutical v. Bartlett.

One of the underlying cases for today‘s decision was the PLIVA, Inc v. Mensing case in 2011 where the Court held that it was impossible for generics to change (much less strengthen) safety warnings to comply with state law and still comply with the federal law’s requirement that their labeling be “the same as” FDA-approved brand drug labeling.

Nathan Mehrens, president of Americans for Limited Government explained, “Attempts by the trial bar to open up generic drug manufacturers to liability because they followed U.S. Food and Drug Administration labeling standards are absurd on their face. If Congress allows this to occur, those who depend upon low cost generics will likely see the prices skyrocket as attorneys across the nation go wild suing manufacturers for following federal law.”

Vermont Senator and Judicial Committee Chairman Patrick Leahy and Congressman Chris Van Hollen (D-MD) decried the Supreme Court decision, calling on the Food and Drug Administration to take regulatory action.  Both Leahy and Van Hollen are expected to introduce legislation designed to open the door for lawsuits against generic drug manufacturers.

The Americans for Limited Government led coalition letter asks Speaker Boehner to “actively oppose such legislation when it is introduced and stop any momentum that it might hope to gain.”

Generics Labeling Legislation Letter 6-26-13


Letter to House Speaker Rep. John Boehner, June 24, 2013, at http://getliberty.org/wp-content/uploads/2013/06/Generics-Labeling-Legislation-Letter-6-26-13.pdf

Copyright © 2008-2021 Americans for Limited Government